Fairfax Financial Holdings’s Strongbridge Biopharma plc. SBBP Stock Holding History

Fairfax Financial Holdings’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-193,107	Closed	-$392K	–	70
2021 Q3	$392K	Hold	193,107	–	–	0.01%	59
2021 Q2	$572K	Buy	+193,107	New	+$510K	0.02%	55

Fairfax Financial Holdings's SBBP Position: Q4 2021 in Review

Fairfax Financial Holdings sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 193,107 shares — an estimated $392K sold.

Fairfax Financial Holdings first reported a position in SBBP in Q2 2021 and held it in 2 quarters. The position peaked at $572K in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Fairfax Financial Holdings reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Fairfax Financial Holdings sold 193,107 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $392K.
Fairfax Financial Holdings first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 2 quarters.
Fairfax Financial Holdings's Strongbridge Biopharma plc. position peaked at $572K in Q2 2021.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Fairfax Financial Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.